Phillip M Trusty1, Zhenglun Alan Wei1, Jack Rychik2, Alexa Graham1, Pierre A Russo3, Lea F Surrey3, David J Goldberg2, Ajit P Yoganathan4, Mark A Fogel2. 1. Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia. 2. Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 3. Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 4. Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia. Electronic address: ajit.yoganathan@bme.gatech.edu.
Abstract
BACKGROUND: Liver fibrosis is a serious complication of single ventricle Fontan survivors. Its causes are of great interest, and potential solutions to halt or delay progression are needed. The purpose of this study is to investigate if prior hemodynamics and anatomy can predict liver fibrosis severity in these patients. METHODS: Twenty-one Fontan patients with cardiac magnetic resonance (CMR) data obtained greater than 1 year before liver biopsy data were included. Computational fluid dynamic simulations were performed to quantify total cavopulmonary connection (TCPC) flow dynamics using patient-specific anatomies and blood flow waveforms reconstructed from CMR data. Collagen deposition (a measure of liver fibrosis) was quantified by digital image analysis of Sirius red-stained slides. Statistical analyses were performed to investigate potential relationships between Fontan hemodynamics and liver fibrosis. RESULTS: With an average time of 6.7 ± 2.9 years (range, 2-11 years) between CMR and biopsy, TCPC resistance and left pulmonary artery stenosis showed significant, positive correlations with magnitude of liver fibrosis (r = 0.54, P = .026; and r = 0.55, P = .028, respectively). The change in inferior vena cava flow rate over time also showed a significant positive correlation with magnitude of liver fibrosis (r = 0.91, P = .001). CONCLUSIONS: TCPC resistance, left pulmonary artery stenosis, and increased inferior vena cava flow are positively associated with liver fibrosis after Fontan operation and hold promise as important predictors of hepatic decline. These findings encourage preprocedural planning and interventional strategies to improve TCPC performance and reduce vessel stenosis. Further investigation is warranted to design the ideal Fontan circulation and optimize flow dynamics to reduce the risk of liver fibrosis.
BACKGROUND:Liver fibrosis is a serious complication of single ventricle Fontan survivors. Its causes are of great interest, and potential solutions to halt or delay progression are needed. The purpose of this study is to investigate if prior hemodynamics and anatomy can predict liver fibrosis severity in these patients. METHODS: Twenty-one Fontan patients with cardiac magnetic resonance (CMR) data obtained greater than 1 year before liver biopsy data were included. Computational fluid dynamic simulations were performed to quantify total cavopulmonary connection (TCPC) flow dynamics using patient-specific anatomies and blood flow waveforms reconstructed from CMR data. Collagen deposition (a measure of liver fibrosis) was quantified by digital image analysis of Sirius red-stained slides. Statistical analyses were performed to investigate potential relationships between Fontan hemodynamics and liver fibrosis. RESULTS: With an average time of 6.7 ± 2.9 years (range, 2-11 years) between CMR and biopsy, TCPC resistance and left pulmonary artery stenosis showed significant, positive correlations with magnitude of liver fibrosis (r = 0.54, P = .026; and r = 0.55, P = .028, respectively). The change in inferior vena cava flow rate over time also showed a significant positive correlation with magnitude of liver fibrosis (r = 0.91, P = .001). CONCLUSIONS:TCPC resistance, left pulmonary artery stenosis, and increased inferior vena cava flow are positively associated with liver fibrosis after Fontan operation and hold promise as important predictors of hepatic decline. These findings encourage preprocedural planning and interventional strategies to improve TCPC performance and reduce vessel stenosis. Further investigation is warranted to design the ideal Fontan circulation and optimize flow dynamics to reduce the risk of liver fibrosis.
Authors: Zhenglun Wei; Shelly Singh-Gryzbon; Phillip M Trusty; Connor Huddleston; Yingnan Zhang; Mark A Fogel; Alessandro Veneziani; Ajit P Yoganathan Journal: Ann Biomed Eng Date: 2020-05-05 Impact factor: 3.934
Authors: Zhenglun Alan Wei; Camille Johnson; Phillip Trusty; Morgan Stephens; Wenjun Wu; Ritchie Sharon; Balaji Srimurugan; Brijesh P Kottayil; G S Sunil; Mark A Fogel; Ajit P Yoganathan; Mahesh Kappanayil Journal: Pediatr Cardiol Date: 2020-05-06 Impact factor: 1.655
Authors: Friso M Rijnberg; Séline F S van der Woude; Mark G Hazekamp; Pieter J van den Boogaard; Hildo J Lamb; Covadonga Terol Espinosa de Los Monteros; Lucia J M Kroft; Sasa Kenjeres; Tawab Karim; Monique R M Jongbloed; Jos J M Westenberg; Jolanda J Wentzel; Arno A W Roest Journal: Eur J Cardiothorac Surg Date: 2022-06-15 Impact factor: 4.534
Authors: Arno A W Roest; Hildo J Lamb; Friso M Rijnberg; Jos J M Westenberg; Hans C van Assen; Joe F Juffermans; Lucia J M Kroft; Pieter J van den Boogaard; Covadonga Terol Espinosa de Los Monteros; Evangeline G Warmerdam; Tim Leiner; Heynric B Grotenhuis; Monique R M Jongbloed; Mark G Hazekamp Journal: J Cardiovasc Magn Reson Date: 2022-03-28 Impact factor: 6.903
Authors: Václav Chaloupecký; Denisa Jičínská; Viktor Tomek; Ondřej Materna; Roman Gebauer; Rudolf Poruban; Petra Antonová; Theodor Adla; Matěj Štefánek; Vojtěch Illinger; Karel Kotaška; Jan Janoušek Journal: Front Cardiovasc Med Date: 2022-09-29